Last updated on July 2019

B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children


Brief description of study

Cohort 1 and 2:

The primary objectives of this study are:

Part A:

  • To evaluate the steady state pharmacokinetics (PK) of bictegravir (BIC) and confirm the dose of the bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) 50/200/25 mg fixed dose combination (FDC) in HIV-1 infected, virologically suppressed adolescents (12 to < 18 years of age) and children (6 to < 12 years of age)

Parts A and B:

  • To evaluate the safety and tolerability of the adult strength B/F/TAF FDC through Week 24 in HIV-1 infected, virologically suppressed adolescents (12 to <18 years of age) and children (6 to <12 years of age)

Cohort 3:

The primary objectives of this study are:

Part A:

  • To evaluate the steady state PK of BIC and confirm the dose of B/F/TAF 30/120/15 mg FDC in HIV-1 infected, virologically suppressed children 2 years of age weighing 14 to < 25 kg

Parts A and B:

  • To evaluate the safety and tolerability of the low dose B/F/TAF FDC tablet through Week 24 in HIV-1 infected, virologically suppressed children 2 years of age weighing 14 to < 25 kg

Clinical Study Identifier: NCT02881320

Find a site near you

Start Over

Gilead Study Team

Fort Pierce, FL United States
  Connect »

Gilead Study Team

Jacksonville, FL United States
  Connect »

Gilead Study Team

Tampa, FL United States
  Connect »

Gilead Study Team

Atlanta, GA United States
  Connect »

Gilead Study Team

Detroit, MI United States
  Connect »

Gilead Study Team

New York, NY United States
  Connect »

Gilead Study Team

Durham, NC United States
  Connect »

Gilead Study Team

Philadelphia, PA United States
  Connect »

Gilead Study Team

Memphis, TN United States
  Connect »

Gilead Study Team

Bloemfontein, South Africa
  Connect »

Gilead Study Team

Cape Town, South Africa
  Connect »

Gilead Study Team

Dundee, South Africa
  Connect »

Gilead Study Team

Durban, South Africa
  Connect »

Gilead Study Team

Johannesburg, South Africa
  Connect »

Gilead Study Team

Pretoria, South Africa
  Connect »

Gilead Study Team

Soweto, South Africa
  Connect »

Gilead Study Team

Khon Kaen, Thailand
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.